
Fundamental analysis: Balchem Corporation (BCPC)
Awarener score: 7.1
Conclusion
The higher the Awarener score, the more bang you get for the buck. It measures how much genuine funds the company generates for the stock price paid (Average), the business stability (Excellent) and growth (Average), and the company's inclination to return cash to the stockholders (Superb).
Note: All scores range from 1 (worst) to 10 (best). Conclusions are updated daily with closing stock prices and new reported quarterly financial statements.
Revenue score: 7.5
- Business has been growing at a low pace. It's been encouraging in relation to peer companies.
- Balchem Corporation business trend stability is excellent. The higher the stability, the lower the risk. It looks top-notch against rivals.
Margins score: 7.3
- BCPC profit margins -on goods and services sold- are usually hardly sufficient. They stand slightly better than rival companies.
- Business profit on sales tends to be very good. It's great when measured against competitors.
- Profits on sales made -available to repay debt and purchase properties- are usually good. They remain excellent in relation to peers.
- Earnings -before income taxes and interests on loans taken- tend to be very good in relation to total revenues. They're still better than most similar companies.
- Profits -before income taxes- are usually very good considering total sales, and remain great when measured against rivals.
- Total net profit tends to be very good when confronted to sales. Company stands great when measured against comparable firms.
Growth score: 3.9
- Balchem Corporation profit -on goods and services sold- has been growing at a low pace. It's been rather normal in relation to competitors.
- In recent years, earnings growth -on operations- have been almost stagnant, which has been somewhat worse than comparable firms.
- Profits -available to repay debt and purchase properties- have been growing at a very low pace, which compares below average when measured against peer enterprises.
- Growth on earnings -before income taxes and interests on loans taken- have been almost stagnant. It turns to be lacking compared to similar stocks.
- In past years, profits -before income taxes- grew at a very low speed. It was somewhat worse than rivals.
- In the previous years, growth on total net profit has been almost null, and below average when measured against peer companies.
- Earnings per share have grown at a low rhythm in past years. It's been rather normal in relation to industry peers.
Miscellaneous score: 8.3
- BCPC had to pay sparse income taxes in relation to profits made in the past years. It's been slightly better than peers.
- Research and development expenses hardly consume a portion of revenues. It's encouraging in relation to competitors.
- The company shows very good business growth in relation to research and development efforts. It stands in good shape compared to rival companies.
Profitability score: 8.8
- Balchem Corporation usually gets excellent returns on the resources it controls. It proves encouraging in relation to peer firms.
- The company normally gets very good proceeds -on the resources directly invested in the business-. They remain rather normal in relation to similar companies.
- There's usually abundant profitability -in relation to owned resources-. It ranks almost average when measured against competitors.
- In the past, got huge returns -on the tangible resources it controls-. This metric is usually related to the industry in which operates and combines profitability versus reinvestment needs. It's great when measured against comparable enterprises.
Usage of Funds score: 6.9
- BCPC usually uses a modest portion of genuine funds generated to buy or replace property, plant, or equipment. The need for reinvestments isn't too high. It stands great when measured against rival firms.
- The company is usually replacing most of the property, plant, and equipment that gets old, and saving a little funds for something else, which is weak when measured against industry peers.
- In the past twelve months it paid very little dividends, considering the current stock price. It came worse than most competitors.
- Has increased dividend payments in the past years. Business prospects may have improved. The company has behaved a slight improvement compared to similar firms.
- Dividend payments usually represent a modest portion of genuine funds generation and should be reasonable safe. Sustainability looks well ranked against comparable companies.
- The company usually significantly reduces the pool of investors, resulting in fewer mouths feeding on the pie of profits. It remains excellent in relation to peer enterprises.
- Repurchase effectiveness metric is very complex. Run again in analytical mode if you're interested in a technical explanation. It stands impressive in relation to rivals.
- The company uses a modest portion of genuine fund generation to reward investors, which can probably be sustained. It still looks more than average in relation to competitors.
Balance Sheet score: 5.1
- Balchem Corporation intangible assets (like brands and goodwill) represent a significant portion of resources controlled, according to accounting books. There could be significant difficulties in liquidating them if the company ever gets in financial distress. It happens to be substantially worse when measured against peer companies.
- The company has more than enough short-term resources to face short-term obligations. Liquidity concerns are non-significant. It turns to be a slight improvement compared to similar firms.
- Roughly a quarter of resources controlled were provided for with financial debt. Creditors have some claims on the company. It remains slightly better than rival firms.
- Most controlled resources might be only slowly turned into cash and equivalents, which is risky. It looks last-in-rank when measured against rivals.
- For every dollar of short-term obligations, the company has more than enough dollars in cash and short-term receivables. It's a slight improvement compared to peer firms.
- For every dollar of short-term obligations, the company has almost another of cash and equivalents, which is somewhat better than similar enterprises.
- Usually, sales are on a two-months credit. It still ranks similar to peers.
- Normally has approximately somewhat more than two months of sales worth in inventory. It comes up as rather normal in relation to competitors.
- On average, it takes higher than four months from the purchase to charging customers. It happens to be somewhat better than peers.
- On average pays suppliers before a month since the purchase. It ranks weak when measured against industry peers.
- The company pays its suppliers roughly three months before charging its customers, so there's sufficient money invested in working capital. It's lacking compared to similar companies.
- Net interest expenses consume a minor portion of usual business earnings, and are easily bearable. It stands slightly better than rival firms.
- Business earnings have usually been good when measured against loans taken. Cutting back reinvesting in the business, it could take less than three years to repay the obligations with current profitability. It ranks similar to comparable enterprises.
- Revenues are modest in relation to property, plant, and equipment required to operate. This metric is likely dependent on the industry the company operates in. The more property, plant, and equipment used, the more the company must reinvest to fight obsolescence, which usually means less available funds for the shareholders in the long run. It looks rather normal in relation to similar firms.
- Resource exploitation is reasonable when yearly sales are considered. This metric is normally tied to the industry where the firm belongs. It's still somewhat worse than peer companies.
Valuation score: 4.7
- Balchem Corporation looks heavily expensive in relation to profits and financial position. It happens to be substantially worse when measured against competitors.
- Price-to-Tangible-Book-Value is a fairly complex metric. Run again in analytical mode if you're interested in a technical explanation. It remains a disappointment compared to peers.
- In the past twelve months, the company generated some free funds in relation to the stock price, which stands somewhat better than similar companies.
- The company usually generates somewhat more than enough genuine funds to cover up for its business needs. Surplus cash may be used to repay loans, to eventually buy new businesses, or to reward investors. Considering the financial position and stock price, the current valuation might be reasonable. It's still below average when measured against industry firms.
- In the past twelve months, the company has significantly rewarded investors, considering both dividends and share on the pie of earnings. It came up excellent in relation to peer ventures.
- The company has neither net debt nor net cash. It may borrow extra money if it wishes so, or start cumulating cash for future uses. It looks somewhat better than similar enterprises.
- Considering the past twelve months, traditional Price-to-Earnings relation is very high. A lot of improvement expectations are already in the stock price, which is risky. It ranks substantially worse when measured against peer companies.
- Comparing the current stock price with the past twelve-months revenues gives a very high relationship. This is an important metric to check its evolution through time, and to compare to industry peers. It looks in a very weak position compared to rival firms.
- The relation between the stock price and accounting book value is really high, which may be good or bad depending on context. Run again in analytic mode if you want to dig deeper. The company remains mediocre against peer firms.
- In the past twelve months, the operating business lost a little money. It happens to be substantially worse when measured against industry peers.
- In an alternate metric of bang for the buck, the company has usually shown a modest earnings power ability when measured against the current stock price and financial position. It's still in a weak position compared to peer companies.
Total score: 6.6

Company at a glance: Balchem Corporation (BCPC)
Sector, industry: Basic Materials, Specialty Chemicals
Market Cap: 4.28 billions
Revenues TTM: 0.95 billions
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Awarener score: 7.1
Conclusion
The higher the Awarener score, the more bang you get for the buck. It measures how much genuine funds the company generates for the stock price paid (Average), the business stability (Excellent) and growth (Average), and the company's inclination to return cash to the stockholders (Superb).